In Vitro to In Vivo Translation of Salivary Concentrations for Non-Invasive Biomonitoring of 2,4-Dichlorophenoxyacetic Acid (2,4-D)
-
2019/03/01
Details
-
Personal Author:
-
Description:Biomonitoring practices generally examine blood and urine to acquire insight regarding chemical exposures. Saliva has become a favorable sample matrix due to its non-invasive attributes and overall flexibility in collection. Relating concentrations measured in saliva to concentrations in blood or urine can be challenging due to gaps in knowledge of mechanisms driving salivary transport. We employed a Transwell in vitro system under physiological conditions to monitor and measure salivary chemical transport of a commonly applied herbicide, 2,4-dichlorophenoxyacetic acid (2,4-D). High levels of protein binding (> 92%) were observed, resulting in transport (primarily via passive diffusion) to the salivary compartment limited by formation of free unbound species, predicting a saliva/plasma ratio of 0.034. Comparatively, a saliva/plasma ratio of 0.0079 was produced from an in vivo study, orally dosing male Sprague-Dawley rats with 30-150 mg/kg 2,4-D and collecting plasma and saliva 1 hour post-exposure. A physiologically based pharmacokinetic (PBPK) model was developed to translate observations from the cell culture model to those in animal models. The PBPK model notably incorporated descriptions of protein binding, salivary/plasma partitioning, and permeation. While apparent differences in in vitro and in vivo saliva/plasma ratios (0.034 and 0.0079, respectively) were observed, simulations with the PBPK model demonstrated dynamic saliva/plasma ratios over time and concordance between the two experimental systems. This indicated that 2,4-D exhibits diffusion limited transport to saliva in vivo, with saliva/plasma ratios requiring longer time after exposure to reach equilibrium, compared to other small organic chemicals like trichloropyridinol. Sampling time after exposures is then a critical component for interpreting salivary 2,4-D biomonitoring data. This work demonstrates the role of PBPK modeling in linking observations made with in vitro and in vivo approaches and additionally allows for further extrapolation of salivary concentrations for human biomonitoring. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:168
-
Issue:1
-
NIOSHTIC Number:nn:20054955
-
Citation:Toxicologist 2019 Mar; 168(1):210
-
CAS Registry Number:
-
Federal Fiscal Year:2019
-
NORA Priority Area:
-
Performing Organization:Battelle Pacific Northwest Laboratories, Richland, Washington
-
Peer Reviewed:False
-
Start Date:20160901
-
Source Full Name:The Toxicologist. Society of Toxicology 58th Annual Meeting and ToxExpo, March 10-14, 2019, Baltimore, Maryland
-
End Date:20200831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:edb2a466880b5e3c1023cbc7c5eda654ad7494c341dd982fa01ef387a1ef5d34f094728d4f6ad7ca02e9c202e402acdce172bc86b3ee4b81dfa5f80fd5a7151c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like